S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
Log in

NYSEAMERICAN:OCXOncoCyte SEC Filings & 10K Form

$2.36
-0.01 (-0.42 %)
(As of 04/7/2020 10:04 AM ET)
Add
Compare
Today's Range
$2.30
Now: $2.36
$2.43
50-Day Range N/A
52-Week Range
$1.50
Now: $2.36
$5.60
Volume11,677 shs
Average Volume265,303 shs
Market Capitalization$147.43 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

OncoCyte (NYSEAMERICAN:OCX) SEC Filings

DateFilerForm TypeView
04/02/2020
7:10 PM
OncoCyte (Issuer)
Ross Douglas T. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2020
8:24 PM
ANDREWS RONALD ASBURY (Reporting)
OncoCyte (Issuer)
Form 4/A
04/01/2020
3:05 PM
ANDREWS RONALD ASBURY (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2020
4:06 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
3:30 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
3:02 PM
OncoCyte (Filer)
Form 424B5
03/17/2020
4:28 PM
OncoCyte (Filer)
Form 8-K/A
03/06/2020
3:52 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
2:02 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
8:54 PM
Levine Mitchell S (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
8:53 PM
KALAJIAN TONY T (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
8:53 PM
OncoCyte (Issuer)
Parker Albert P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
8:52 PM
OncoCyte (Issuer)
Sundar Padma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
8:45 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
4:27 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:38 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
4:29 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
4:28 PM
OncoCyte (Filer)
Form 424B5
12/27/2019
4:16 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
10:43 AM
OncoCyte (Subject)
PURA VIDA INVESTMENTS, LLC (Filed by)
Form SC 13G
11/15/2019
4:57 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
3:05 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
5:33 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
5:32 AM
OncoCyte (Filer)
Form 424B5
10/21/2019
3:15 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
3:59 PM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
4:28 PM
KALAJIAN TONY T (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
4:20 PM
Lineage Cell Therapeutics, Inc. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
4:18 PM
Lineage Cell Therapeutics, Inc. (Filed by)
OncoCyte (Subject)
Form SC 13D/A
09/13/2019
4:08 PM
BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
Form SC 13D/A
09/13/2019
3:57 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
5:33 PM
Levine Mitchell S (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
4:28 PM
OncoCyte (Filer)
Form 8-K/A
09/05/2019
7:05 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
3:56 PM
KALAJIAN TONY T (Reporting)
OncoCyte (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2019
4:28 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
3:16 PM
OncoCyte (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2019
7:35 PM
GRIFFITH MELINDA (Reporting)
OncoCyte (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/23/2019
3:54 PM
OncoCyte (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/23/2019
3:44 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
8:38 PM
OncoCyte (Issuer)
Redmond Cavan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
7:31 PM
MOHANTY ADITYA P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
7:23 PM
KINGSLEY ALFRED D (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
7:12 PM
Last Andrew J. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
7:06 PM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2019
3:56 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
3:32 PM
BIOTIME INC (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2019
3:30 PM
BIOTIME INC (Filed by)
OncoCyte (Subject)
Form SC 13D/A
07/03/2019
5:44 PM
ANDREWS RONALD ASBURY (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:09 PM
BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
Form SC 13D/A
06/26/2019
4:21 PM
OncoCyte (Filer)
Form DEFA14A
06/18/2019
11:15 PM
OncoCyte (Filer)
Form EFFECT
06/18/2019
5:15 AM
OncoCyte (Filer)
Form DEFA14A
06/18/2019
5:05 AM
OncoCyte (Filer)
Form DEF 14A
06/06/2019
5:35 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
8:59 PM
OncoCyte (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/03/2019
7:30 PM
OncoCyte (Issuer)
Sundar Padma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2019
6:54 AM
KARFUNKEL GEORGE (Filed by)
OncoCyte (Subject)
Form SC 13G
05/14/2019
3:25 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:17 PM
OncoCyte (Filer)
Form 10-K/A
04/18/2019
4:06 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:42 PM
OncoCyte (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2019
3:35 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
3:25 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
7:06 PM
ANNETT WILLIAM (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
7:02 PM
Levine Mitchell S (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
6:58 PM
HESTERBERG LYNDAL K. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
6:53 PM
OncoCyte (Issuer)
Parker Albert P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
8:56 PM
MOHANTY ADITYA P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2019
4:23 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2019
4:16 PM
BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
Form SC 13D/A
02/12/2019
3:51 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
5:06 AM
OncoCyte (Filer)
Form 424B5
02/08/2019
5:06 AM
OncoCyte (Filer)
Form 424B5
02/07/2019
3:22 PM
OncoCyte (Filer)
Form 424B5
01/29/2019
6:00 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2019
4:05 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
3:16 PM
OncoCyte (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2018
3:10 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
3:01 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
8:51 PM
KINGSLEY ALFRED D (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
8:45 PM
Last Andrew J. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
8:40 PM
ANDREWS RONALD ASBURY (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
8:37 PM
OncoCyte (Issuer)
Redmond Cavan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
8:33 PM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2018
3:39 PM
OncoCyte (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/21/2018
8:47 PM
BIOTIME INC (Filed by)
OncoCyte (Subject)
Form SC 13D/A
08/16/2018
8:34 PM
OncoCyte (Issuer)
Parker Albert P (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2018
3:30 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
8:40 PM
ANNETT WILLIAM (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2018
8:39 PM
ANDREWS RONALD ASBURY (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2018
8:39 PM
Levine Mitchell S (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2018
8:39 PM
OncoCyte (Issuer)
Redmond Cavan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2018
8:38 PM
HESTERBERG LYNDAL K. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2018
8:38 PM
Last Andrew J. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2018
8:38 PM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2018
7:53 PM
OncoCyte (Filer)
Form DEFA14A
07/27/2018
4:31 PM
OncoCyte (Filer)
Form 424B5
07/09/2018
3:10 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2018
4:01 PM
OncoCyte (Filer)
Form PRE 14A
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel